NCT00000863View on ClinicalTrials.gov

A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

Not specified

Study Completion Date

July 31, 1998

Conditions
Pneumonia, Pneumocystis CariniiHIV Infections
Interventions
DRUG

Sitamaquine

Trial Locations (12)

10016

NY Univ. HIV/AIDS CRS, New York

14215

SUNY - Buffalo, Erie County Medical Ctr., Buffalo

35294

Alabama Therapeutics CRS, Birmingham

43210

The Ohio State Univ. AIDS CRS, Columbus

45267

Univ. of Cincinnati CRS, Cincinnati

46202

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

Indiana Univ. School of Medicine, Wishard Memorial, Indianapolis

Methodist Hosp. of Indiana, Indianapolis

60611

Northwestern University CRS, Chicago

60640

Weiss Memorial Hosp., Chicago

96816

Queens Med. Ctr., Honolulu

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000863 - A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients | Biotech Hunter | Biotech Hunter